To Our Harmony Residents & Families,
Part of our responsibility as a "Family Serving Families" company is to keep you updated on any available information related to our fight against COVID-19. You may have heard updates related to the COVID-19 booster shot. I wanted to share with you the most recent update from the CDC regarding the booster shot.
Our COVID-19 Taskforce continues to meet every day and reviews all updates related to the COVID-19 booster, and we are in close contact with our pharmacies to ensure that our communities are a priority in receiving clinics for these booster shots when they are available. We are coordinating clinics in each community to offer the booster and flu vaccine for our residents and associates.
We will continue to keep you updated on our website and with email communications. Harmony continues to employ all of our current COVID-19 precautions and prevention methods including testing, masking, and sanitizing. We sincerely thank you for your continued support.
Terry Howard, CEO
Harmony Senior Services
CDC Statement on ACIP Booster Recommendations
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations and also recommended a booster dose for those in high risk occupational and institutional settings. The Food and Drug Administration's (FDA) authorization and CDC's guidance for use are important steps forward as we work to stay ahead of the virus and keep Americans safe.
This updated interim guidance from CDC allows for millions of Americans who are at the highest risk for COVID-19 to receive a Pfizer-BioNTech COVID-19 booster shot to help increase their protection.
- people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech's COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.
- people aged 50-64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech's COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.
- people aged 18-49 years with underlying medical conditions may receive a booster shot of Pfizer-BioNTech's COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
- and people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech's COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
Many of the people who are now eligible to receive a booster shot received their initial vaccine early in the vaccination program and will benefit from additional protection. With the Delta variant's dominance as the circulating strain and cases of COVID-19 increasing significantly across the United States, a booster shot will help strengthen protection against severe disease in those populations who are at high risk for exposure to COVID-19 or the complications from severe disease.